A Comparison of PT027 vs PT007 Used as Needed in Participants With Asthma
Status:
Not yet recruiting
Trial end date:
2024-05-18
Target enrollment:
Participant gender:
Summary
This is a US study comparing the efficacy and safety of BDA MDI [Budesonide/Albuterol Sulfate
(BDA) metered dose inhaler (MDI)] with AS [Albuterol Sulfate] MDI, both are administered as
needed for up to 12 months.